Update on corticosteroids for diabetic macular edema
Clinical Ophthalmology, 2016 Diabetic macular edema (DME) remains an important cause of visual loss. Although anti-vascular endothelial growth factor (VEGF) agents are generally used as first-line treatments for patients with center-involving DME, there is an important role for corticosteroids as well.
Harry W. Flynn +3 more
openaire +4 more sources
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang +8 more
wiley +1 more source
Deep learning architecture LightOCT for diagnostic decision support using optical coherence tomography images of biological samples [PDF]
arXiv, 2018 Optical coherence tomography (OCT) is being increasingly adopted as a label-free and non-invasive technique for biomedical applications such as cancer and ocular disease diagnosis. Diagnostic information for these tissues is manifest in textural and geometric features of the OCT images, which are used by human expertise to interpret and triage. However,
arxiv
Topical latanoprost does not cause macular thickening after uncomplicated cataract surgery. [PDF]
, 2012 PurposeTo explore changes in central macular thickness (CMT) after a two-month period of glaucoma therapy with topical latanoprost after uneventful phacoemulsification.MethodsForty-one eyes of 31 patients with primary open angle or pseudoexfoliative ...
Amini, Heydar +7 more
core +1 more source
Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema [PDF]
, 2003 Jost B. Jonas +3 more
openalex +1 more source
Activatable Photosensitizers: From Fundamental Principles to Advanced Designs
Angewandte Chemie, Volume 137, Issue 15, April 7, 2025.Basic concepts of designing activatable photosensitizers are established in this Review by closely examining quenching mechanisms and bioresponsive constructs essential for their function. New strategies developed in the last five years that address the shortcomings of conventional activatable photosensitizers and which enhance selectivity are also ...
Nahyun Kwon +3 more
wiley +2 more sources
Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema
Clinical Ophthalmology, 2015 John Hall Alimera Sciences Ltd., Aldershot, Hampshire, UK I read “Dexamethasone intravitreal implant in the treatment of diabetic macular edema” published July 2015 by Dugel et al.1This article is very interesting in terms of providing an
Hall J
doaj
Endothelial Nitric Oxide Synthase Gene Is Associated With Diabetic Macular Edema in Type 2 Diabetes [PDF]
, 2004 Takuya Awata +15 more
openalex +1 more source
Mesenchymal Stem Cell‐Derived Exosomes: A Promising Therapeutic Strategy for Age‐Related Diseases
Cell Proliferation, EarlyView.Mechanisms of MSC‐Exos in the treatment of age‐related diseases. A Immunomodulatory and anti‐inflammatory, MSC‐Exos mediate immunomodulatory and anti‐inflammatory effects by regulating the polarisation of T cells and macrophages, promoting an anti‐inflammatory state while inhibiting pro‐inflammatory responses; B Suppression of oxidative stress, MSC ...
Bohua Wei +5 more
wiley +1 more source
Deep Learning-Based Detection of Referable Diabetic Retinopathy and Macular Edema Using Ultra-Widefield Fundus Imaging [PDF]
arXivDiabetic retinopathy and diabetic macular edema are significant complications of diabetes that can lead to vision loss. Early detection through ultra-widefield fundus imaging enhances patient outcomes but presents challenges in image quality and analysis scale.
arxiv